Skip to content
PICO Portalanswers from OpenAlex

Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy

PaperCitations, authors & open-access status

Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy is a paper indexed in PICO Portal from OpenAlex.

How many citations does Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy have?

PICO Portalcitation count

Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy has 126 citations in the OpenAlex counts PICO Portal stores.

When was Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy published?

PICO Portalyear

Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy has 2006 year in the PICO Portal index.

What is the open-access status of Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy?

PICO Portaloa status

Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy has closed oa status in the PICO Portal index.

What is the DOI of Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy?

PICO Portaldoi

The DOI for Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy is on the source record.

What is the PMID of Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy?

PICO Portalpmid

The PMID for Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy is on the source record.

What is the OpenAlex record for Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy?

PICO Portalopenalex

The OpenAlex for Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial